Literature DB >> 18256293

Immortalization of neural precursors when telomerase is overexpressed in embryonal carcinomas and stem cells.

Anneke E Schwob1, Lilly J Nguyen, Karina F Meiri.   

Abstract

The DNA repair enzyme telomerase maintains chromosome stability by ensuring that telomeres regenerate each time the cell divides, protecting chromosome ends. During onset of neuroectodermal differentiation in P19 embryonal carcinoma (EC) cells three independent techniques (Southern blotting, Q-FISH, and Q-PCR) revealed a catastrophic reduction in telomere length in nestin-expressing neuronal precursors even though telomerase activity remained high. Overexpressing telomerase protein (mTERT) prevented telomere collapse and the neuroepithelial precursors produced continued to divide, but deaggregated and died. Addition of FGF-2 prevented deaggregation, protected the precursors from the apoptotic event that normally accompanies onset of terminal neuronal differentiation, allowed them to evade senescence, and enabled completion of morphological differentiation. Similarly, primary embryonic stem (ES) cells overexpressing mTERT also initiated neuroectodermal differentiation efficiently, acquiring markers of neuronal precursors and mature neurons. ES precursors are normally cultured with FGF-2, and overexpression of mTERT alone was sufficient to allow them to evade senescence. However, when FGF-2 was removed in order for differentiation to be completed most neural precursors underwent apoptosis indicating that in ES cells mTERT is not sufficient allow terminal differentiation of ES neural precursors in vitro. The results demonstrate that telomerase can potentiate the transition between pluripotent stem cell and committed neuron in both EC and ES cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18256293      PMCID: PMC2291397          DOI: 10.1091/mbc.e06-11-1013

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  48 in total

Review 1.  Emerging roles for telomerase in regulating cell differentiation and survival: a neuroscientist's perspective.

Authors:  M P Mattson; W Fu; P Zhang
Journal:  Mech Ageing Dev       Date:  2001-05-31       Impact factor: 5.432

2.  Telomere measurement by quantitative PCR.

Authors:  Richard M Cawthon
Journal:  Nucleic Acids Res       Date:  2002-05-15       Impact factor: 16.971

3.  Real-time quantitative PCR of telomere length.

Authors:  Marcel E Gil; Thérèsa L Coetzer
Journal:  Mol Biotechnol       Date:  2004-06       Impact factor: 2.695

4.  Inhibition of the Rho/ROCK pathway reduces apoptosis during transplantation of embryonic stem cell-derived neural precursors.

Authors:  Masaomi Koyanagi; Jun Takahashi; Yoshiki Arakawa; Daisuke Doi; Hitoshi Fukuda; Hideki Hayashi; Shuh Narumiya; Nobuo Hashimoto
Journal:  J Neurosci Res       Date:  2008-02-01       Impact factor: 4.164

5.  Visualizing telomere dynamics in living mammalian cells using PNA probes.

Authors:  Chris Molenaar; Karien Wiesmeijer; Nico P Verwoerd; Shadi Khazen; Roland Eils; Hans J Tanke; Roeland W Dirks
Journal:  EMBO J       Date:  2003-12-15       Impact factor: 11.598

Review 6.  Telomeres, stem cells, senescence, and cancer.

Authors:  Norman E Sharpless; Ronald A DePinho
Journal:  J Clin Invest       Date:  2004-01       Impact factor: 14.808

Review 7.  Clues to catastrophic telomere loss in mammals from yeast telomere rapid deletion.

Authors:  Arthur J Lustig
Journal:  Nat Rev Genet       Date:  2003-11       Impact factor: 53.242

8.  Evidence that high telomerase activity may induce a senescent-like growth arrest in human fibroblasts.

Authors:  Vera Gorbunova; Andrei Seluanov; Olivia M Pereira-Smith
Journal:  J Biol Chem       Date:  2002-12-19       Impact factor: 5.157

9.  Telomerase immortalization of neuronally restricted progenitor cells derived from the human fetal spinal cord.

Authors:  Neeta S Roy; Takahiro Nakano; H Michael Keyoung; Martha Windrem; William K Rashbaum; M Lita Alonso; Jian Kang; Weiguo Peng; Melissa K Carpenter; Jane Lin; Maiken Nedergaard; Steven A Goldman
Journal:  Nat Biotechnol       Date:  2004-02-15       Impact factor: 54.908

10.  SYBR Green real-time telomeric repeat amplification protocol for the rapid quantification of telomerase activity.

Authors:  Henning Wege; Michael S Chui; Hai T Le; Julie M Tran; Mark A Zern
Journal:  Nucleic Acids Res       Date:  2003-01-15       Impact factor: 16.971

View more
  6 in total

1.  Effects of a growth hormone-releasing hormone antagonist on telomerase activity, oxidative stress, longevity, and aging in mice.

Authors:  William A Banks; John E Morley; Susan A Farr; Tulin O Price; Nuran Ercal; Irving Vidaurre; Andrew V Schally
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-06       Impact factor: 11.205

2.  Stable expression of FoxA1 promotes pluripotent P19 embryonal carcinoma cells to be neural stem-like cells.

Authors:  Difei Dong; Lei Meng; Qiqi Yu; Guixiang Tan; Miao Ding; Yongjun Tan
Journal:  Gene Expr       Date:  2012

3.  Effect of EGF and FGF on the expansion properties of human umbilical cord mesenchymal cells.

Authors:  Parvin Salehinejad; Noorjahan Banu Alitheen; Ali Mandegary; Seyed Noureddin Nematollahi-Mahani; Ehsan Janzamin
Journal:  In Vitro Cell Dev Biol Anim       Date:  2013-05-25       Impact factor: 2.416

4.  TRF2 recruits nucleolar protein TCOF1 to coordinate telomere transcription and replication.

Authors:  Xin Nie; Danqing Xiao; Yuanlong Ge; Yujie Xie; Haoxian Zhou; Tian Zheng; Xiaocui Li; Haiying Liu; Hui Huang; Yong Zhao
Journal:  Cell Death Differ       Date:  2020-10-20       Impact factor: 15.828

5.  Foxm1 transcription factor is required for maintenance of pluripotency of P19 embryonal carcinoma cells.

Authors:  Zhongqiu Xie; Guixiang Tan; Miao Ding; Difei Dong; Tuanhui Chen; Xiangxian Meng; Xiaoqin Huang; Yongjun Tan
Journal:  Nucleic Acids Res       Date:  2010-08-11       Impact factor: 16.971

Review 6.  The Emerging Roles for Telomerase in the Central Nervous System.

Authors:  Meng-Ying Liu; Ashley Nemes; Qi-Gang Zhou
Journal:  Front Mol Neurosci       Date:  2018-05-16       Impact factor: 5.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.